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Spread of  
Cantagalo Virus to 
Northern Brazil
To the Editor: Cantagalo virus 
(CTGV) is a strain of vaccinia virus 
(VACV;  Poxviridae)  that  was  iso-
lated  from  pustular  lesions  on  dairy 
cattle  and  dairy  workers  in  Rio  de 
Janeiro  State,  Brazil,  in  1999  (1). 
Subsequently,  similar  lesions  caused 
by poxviruses have been reported in 
cattle  and  humans  in  all  4  states  of 
the southeast region of Brazil and in 
Goiás State in central-western Brazil 
(online Technical Appendix, panel A, 
available  from  www.cdc.gov/EID/ 
content/15/7/1142-Techapp.pdf)  (2–7).   
Etiologic agents were VACV strains, 
most of which were genetically related 
to CTGV, such as Araçatuba and Pas-
satempo viruses (2,4), with the excep-
tion of Guarani P1 virus, which was 
isolated in Minas Gerais State in 2001 
and is phylogenetically close to VACV 
strain WR (5). Reisolation of Guarani 
P1  virus  has  not  been  reported. All 
VACV isolates related to CTGV share 
2 molecular signatures: an 18-nt dele-
tion in the A56R gene, which encodes 
viral hemagglutinin (1–7), and a 15-nt 
deletion in K2L gene, which encodes 
serine protease inhibitor-3 (8,9). Other 
VACV strains unrelated to CTGV were 
isolated from rodents in Brazil before 
1999, but reisolation of these viruses 
has not been described (8). Although 
CTGV-like  disease  has  not  been  re-
ported  in  the  northern,  northeastern, 
and southern regions of the country, 
rapid interstate spread of CTGV infec-
tion is of concern. We report an epi-
sode of CTGV infection in Tocantins 
State, northern Brazil (online Techni-
cal Appendix, panel A). 
In September 2008, teat and ud-
der lesions were found on 15 of 356 
febrile  (39.5°C–40°C)  cattle  on  a 
dairy farm in the municipality of Mu-
ricilândia.  Small  papules  progressed 
to vesicles and pustules (online Tech-
nical Appendix, panel B), which usu-
ally healed in 3–4 weeks. New lesions 
subsequently appeared on previously 
healthy cows on the same farm, and 
muzzle lesions developed on suckling 
calves. Dairy workers reported fever 
and lesions on their hands and neck. 
The farm was quarantined for 3 weeks 
until the condition was diagnosed. 
Four scab samples were sent for 
virus identification by PCR. Parts of 
the samples were used to infect BSC-
40  cells  and  for  DNA  isolation  by 
phenol-chloroform  extraction,  as  de-
scribed (6). After 48 hours, a strong 
cytopathic  effect  suggested  poxvirus 
infection.  The  PCR  used  unambigu-
ously  differentiates  CTGV-related 
infections  from  other  orthopoxvirus 
diseases, including cowpox virus and 
several VACV strains (6). The reverse 
primer  targets  nucleotide  sequences 
flanking the deletion signature of the 
hemagglutinin  gene  from  CTGV-
related  viruses. Therefore,  a  specific 
annealing site for the reverse primer 
is  produced  when  these  external  se-
quences are contiguous, as occurs in 
CTGV (6). 
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The  full-length  hemagglutinin 
gene  (≈900  bp)  was  detected  in  all 
clinical  isolates  and  in  the  control 
DNA  samples  from  CTGV,  VACV 
strain  WR,  and  cowpox  virus  strain 
Brighton-red  (online  Technical  Ap-
pendix, panel C). Nevertheless, when 
we used the primers specific for CTGV 
detection, only CTGV and the 4 iso-
lates were positive, generating 714-bp 
fragments, which indicated CTGV as 
the etiologic agent. In late November, 
the disease was reported in 9 cattle in 
Santa Fé do Araguaia, a municipality 
12  km  west  of  Muricilândia.  Those 
samples were also positive for CTGV 
by PCR (data not shown).
For  phylogenetic  inference,  we 
used  DNA  from  the  isolate  MU-07 
to  sequence  the  genes  A56R  (927 
bp),  C7L  (453  bp)  that  encodes  a 
host-range virulence factor, and K2L 
(1095 bp); primers aligned externally 
to the open reading frames. PCR and 
sequencing  were  performed  as  de-
scribed elsewhere (1). Sequences were 
deposited in GenBank (accession nos. 
FJ545689, FJ545688, and FJ545687, 
respectively).  Nucleotide  identities 
in relation to CTGV sequences were 
99.8%  (A56R),  100%  (C7L),  and 
100%  (K2L).  Both  A56R  and  K2L 
genes had deletions considered to be 
molecular  signatures  for  Brazilian 
VACV related to CTGV. Phylogenetic 
inference of the concatenated nucle-
otide  dataset  of  27  orthopoxviruses 
shows that the causative agent grouped 
with other Brazilian VACV related to 
CTGV  (online  Technical  Appendix, 
panel D).
We  consider  the  etiologic  agent 
of the infection in Tocantins State to 
be a CTGV isolate, indicating spread 
of CTGV infection to northern Bra-
zil. This spread could reflect interstate 
propagation of the virus due to move-
ment of animals or people, which is 
particularly  intense  at  the  southern 
border with Goiás State (location of 
the nearest CTGV outbreak) (3). Nev-
ertheless,  no  epidemiologic  data  are 
available to support a relationship be-
tween these episodes. The Agency for 
Animal Health Defense of Tocantins 
State has not been previously notified 
of clinical suspicion of poxvirus infec-
tion in dairy herds. 
Another concern is spread of the 
virus to water buffalo, which account 
for a growing farming industry in Bra-
zil, specifically in the northern states 
(www.ibge.gov.br/english).  Infected 
buffalo have not yet been reported in 
Brazil, but the establishment of VACV 
strains in buffaloes has long been re-
ported in India; economic losses have 
been substantial (9). Therefore, a care-
ful  survey  should  be  conducted  to 
evaluate dissemination of the virus to 
other states and species in the Amazon 
region. 
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